Table 4.

First VTE event within 6 months from discharge (%) stratified by cancer site and chemotherapy

Cancer site	No. of people alive and no VTE during hospitalisation	Chemotherapy	VTE	%	No chemotherapy	VTE	%
Breast	485,009	138,776	1871	1.35	346,233	1772	0.51
Lung	278,182	71,155	2389	3.36	207,027	4047	1.95
Bowel	364,489	96,577	1853	1.92	267,912	3782	1.41
Prostate	335,231	17,687	180	1.02	317,544	2011	0.63
Non-Hodgkin lymphoma	113,989	60,495	1165	1.93	53,494	990	1.85
Malignant melanoma	82,445	4088	20	0.49	78,357	135	0.17
Bladder	217,217	32,418	291	0.90	184,799	1256	0.68
Kidney	60,755	4458	61	1.37	56,297	663	1.18
Oesophageal	79,812	22,786	1063	4.67	57,026	1316	2.31
Stomach	66,314	14,916	726	4.87	51,398	1160	2.26
Pancreatic	52,296	12,015	625	5.20	40,281	1290	3.20
Leukaemia	86,648	23,957	287	1.20	62,691	641	1.02
Uterus	68,516	7615	146	1.92	60,901	559	0.92
Ovarian	57,162	28,259	613	2.17	28,903	701	2.43
Oral	62,784	12,080	114	0.94	50,704	264	0.52
Brain	55,107	6726	135	2.01	48,381	1218	2.52
Multiple myeloma	48,944	18,175	348	1.91	30,769	685	2.23
Liver	36,485	5228	155	2.96	31,257	628	2.01
Cervix	30,596	7651	177	2.31	22,945	282	1.23
Laryngeal	22,879	2711	15	0.55	20,168	71	0.35
Testicular	22,481	9119	103	1.13	13,362	98	0.73
Bone/connective tissue	26,490	4231	78	1.84	22,259	215	0.97
Thyroid	21,368	717	3	0.42	20,651	53	0.26
Mesothelioma	17,350	4908	120	2.44	12,442	229	1.84
Other site	87,853	36,920	476	1.30	50,933	714	1.40
Unknown	163,390	25,095	1128	4.49	138,295	2894	2.09
Total	2,943,792	668,763	14,142	2.11	2,275,029	27,674	1.22